1. Home
  2. MOLN vs BZUN Comparison

MOLN vs BZUN Comparison

Compare MOLN & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • BZUN
  • Stock Information
  • Founded
  • MOLN 2004
  • BZUN 2007
  • Country
  • MOLN Switzerland
  • BZUN China
  • Employees
  • MOLN N/A
  • BZUN N/A
  • Industry
  • MOLN
  • BZUN Catalog/Specialty Distribution
  • Sector
  • MOLN
  • BZUN Consumer Discretionary
  • Exchange
  • MOLN Nasdaq
  • BZUN Nasdaq
  • Market Cap
  • MOLN 136.1M
  • BZUN 144.4M
  • IPO Year
  • MOLN 2021
  • BZUN N/A
  • Fundamental
  • Price
  • MOLN $3.60
  • BZUN $2.64
  • Analyst Decision
  • MOLN
  • BZUN Buy
  • Analyst Count
  • MOLN 0
  • BZUN 2
  • Target Price
  • MOLN N/A
  • BZUN $3.20
  • AVG Volume (30 Days)
  • MOLN 1.9K
  • BZUN 260.5K
  • Earning Date
  • MOLN 08-25-2025
  • BZUN 08-27-2025
  • Dividend Yield
  • MOLN N/A
  • BZUN N/A
  • EPS Growth
  • MOLN N/A
  • BZUN N/A
  • EPS
  • MOLN N/A
  • BZUN N/A
  • Revenue
  • MOLN $2,525,030.00
  • BZUN $1,310,110,798.00
  • Revenue This Year
  • MOLN N/A
  • BZUN $5.27
  • Revenue Next Year
  • MOLN $866.67
  • BZUN $3.46
  • P/E Ratio
  • MOLN N/A
  • BZUN N/A
  • Revenue Growth
  • MOLN N/A
  • BZUN 6.77
  • 52 Week Low
  • MOLN $3.36
  • BZUN $2.11
  • 52 Week High
  • MOLN $12.22
  • BZUN $4.38
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 44.28
  • BZUN 47.79
  • Support Level
  • MOLN $3.71
  • BZUN $2.56
  • Resistance Level
  • MOLN $3.89
  • BZUN $2.74
  • Average True Range (ATR)
  • MOLN 0.12
  • BZUN 0.13
  • MACD
  • MOLN -0.00
  • BZUN 0.01
  • Stochastic Oscillator
  • MOLN 15.87
  • BZUN 47.25

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

Share on Social Networks: